TRACON Pharmaceuticals

-$0.03 (-1.50%) As of 4:35 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TCON and other ETFs, options, and stocks.

About TCON

TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. Its products include TRC105, an anti-endoglin antibody for the treatment of solid tumor types, TRC205 created for the treatment of fibrotic diseases, and TRC102, a small molecule that is in clinical development made for lung cancer and glioblastoma.

CEO
Charles P. Theuer
Employees
19
Headquarters
San Diego, California
Founded
2004

TCON Key Statistics

Market cap
39.56M
Price-Earnings ratio
—
Dividend yield
—
Average volume
131.02K
High today
$1.98
Low today
$1.92
Open price
$1.92
Volume
27.76K
52 Week high
$7.09
52 Week low
$1.24

TCON Earnings

-$0.58
-$0.39
-$0.19
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Aug 10, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure